Biogen Inc. buy BMO Capital Markets
Start price
14.02.24
/
50%
€206.60
Target price
14.02.25
€265.53
Performance (%)
-18.13%
Price
04.10.24
€169.15
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -18.13%. This prediction currently runs until 14.02.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -2.983% | -2.983% |
iShares Core DAX® | -1.114% | 5.062% |
iShares Nasdaq 100 | 1.816% | 9.828% |
iShares Nikkei 225® | 2.113% | 8.218% |
iShares S&P 500 | 2.038% | 7.448% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $295.00 to $285.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat